Aplus Biotechnology Corporation Limited (TPEX:6918)
Taiwan
· Delayed Price · Currency is TWD 109.50
-0.50 (-0.45%)
Apr 2, 2025, 2:47 PM CST
TPEX:6918 Market Cap
TPEX:6918 has a market cap or net worth of 3.34 billion as of April 2, 2025. Its market cap has increased by 114.29% in one year.
Market Cap
3.34B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
109.50
Market Cap Chart
Since January 6, 2023, TPEX:6918's market cap has increased from 1.52B to 3.34B, an increase of 119.00%. That is a compound annual growth rate of 42.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 3.35B | 37.16% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 176.51B |
| Caliway Biopharmaceuticals | 113.99B |
| Bora Pharmaceuticals Co., LTD. | 71.78B |
| Lotus Pharmaceutical | 62.09B |
| Oneness Biotech | 32.98B |
| Lumosa Therapeutics | 29.22B |
| Pegavision | 28.08B |
| Polaris Group | 27.65B |